Skip to main content
logo
Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.005
+0.022 (2.28%)
Jan 2, 2026, 10:00 AM EST - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202010 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2010 - 2019
Cellular Immunotherapies
13.63M
Log In
Log In
Log In
Log In
Upgrade
Cellular Immunotherapies Growth
-78.55%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202010 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2010 - 2019
United States
13.63M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-78.55%
Log In
Log In
Log In
Log In
Upgrade